Short reportsWorld distribution of factor V Leiden
References (11)
The molecular genetics of familial venous thombosis
Baillière's Clin Haematol
(1994)- et al.
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
Lancet
(1993) - et al.
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
Blood
(1995) - et al.
Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families
Blood
(1994) - et al.
Epidemiology of coagulation disorders
Baillière's Clin Haematol
(1992)
There are more references available in the full text version of this article.
Cited by (1159)
Fibrinolysis biomarker, thrombin, and activated protein C level alterations after coagulation activation depend on type of thrombophilia and clinical phenotype
2024, Research and Practice in Thrombosis and HaemostasisDifferences in thrombin and plasmin generation potential between East African and Western European adults: The role of genetic and non-genetic factors
2022, Journal of Thrombosis and HaemostasisDisorders of Hemostasis and Thrombosis
2022, Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics: Hematologic, Renal, and Immunologic DisordersMaxillofacial and oral surgery in patients with thrombophilia: safe territory for the oral surgeon? A single-center retrospective study
2021, Oral Surgery, Oral Medicine, Oral Pathology and Oral RadiologyDo we need more guidance on thrombophilia testing? Challenges and special considerations
2024, Expert Review of Hematology
Copyright © 1995 Published by Elsevier Ltd.